ATE460475T1 - Methode zur verhinderung der transplantatabstossung unter verwendung von tgf- beta zur induktion von t-suppressorzellen - Google Patents
Methode zur verhinderung der transplantatabstossung unter verwendung von tgf- beta zur induktion von t-suppressorzellenInfo
- Publication number
- ATE460475T1 ATE460475T1 AT01926893T AT01926893T ATE460475T1 AT E460475 T1 ATE460475 T1 AT E460475T1 AT 01926893 T AT01926893 T AT 01926893T AT 01926893 T AT01926893 T AT 01926893T AT E460475 T1 ATE460475 T1 AT E460475T1
- Authority
- AT
- Austria
- Prior art keywords
- tgf
- induce
- beta
- transplant rejection
- suppressor cells
- Prior art date
Links
- 206010052779 Transplant rejections Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/22—Immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/418—Antigens related to induction of tolerance to non-self
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4225—Growth factors
- A61K40/4229—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19644600P | 2000-04-11 | 2000-04-11 | |
| PCT/US2001/011898 WO2001077299A2 (en) | 2000-04-11 | 2001-04-11 | A METHOD TO PREVENT GRAFT REJECTION USING TGF-β TO INDUCE T SUPPRESSOR CELLS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE460475T1 true ATE460475T1 (de) | 2010-03-15 |
Family
ID=22725449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01926893T ATE460475T1 (de) | 2000-04-11 | 2001-04-11 | Methode zur verhinderung der transplantatabstossung unter verwendung von tgf- beta zur induktion von t-suppressorzellen |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US6759035B2 (de) |
| EP (1) | EP1274833B1 (de) |
| JP (1) | JP5008810B2 (de) |
| AT (1) | ATE460475T1 (de) |
| AU (2) | AU5340001A (de) |
| CA (1) | CA2405806A1 (de) |
| DE (1) | DE60141510D1 (de) |
| WO (1) | WO2001077299A2 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6358506B1 (en) * | 1997-11-05 | 2002-03-19 | University Of Southern California | Use of cytokines and mitogens to inhibit pathological immune responses |
| US20030157057A1 (en) * | 1999-05-05 | 2003-08-21 | Horwitz David A. | Methods for the induction of professional and cytokine-producing regulatory T cells |
| EP1061949B1 (de) | 1998-03-03 | 2009-07-15 | University of Southern California | Zytokinen und mitogenen um "graft-versus-host disease" zu verhindern |
| US6803036B1 (en) | 1998-03-03 | 2004-10-12 | University Of Southern California | Use of cytokines, cells and mitogens to inhibit graft versus host disease |
| ATE460475T1 (de) * | 2000-04-11 | 2010-03-15 | Univ Southern California | Methode zur verhinderung der transplantatabstossung unter verwendung von tgf- beta zur induktion von t-suppressorzellen |
| US7727523B2 (en) * | 2001-08-13 | 2010-06-01 | Yale University | Method for suppressing immune system response to transplanted tissue or cells |
| AU2002364230B2 (en) * | 2001-12-21 | 2008-05-01 | University Of Southern California | Methods for the induction of professional and cytokine-producing regulatory cells |
| US7172907B2 (en) * | 2003-03-21 | 2007-02-06 | Ge Healthcare Bio-Sciences Corp. | Cyanine dye labelling reagents with meso-substitution |
| CA2585462A1 (en) * | 2004-10-29 | 2006-05-11 | Benaroya Research Institute At Virginia Mason | Methods of generating antigen-specific cd4+cd25+ regulatory t cells, compositions and methods of use |
| AU2006232374B2 (en) * | 2005-04-01 | 2011-08-25 | University Of Southern California | Preventing rejection of transplanted tissue using regulatory T cells |
| WO2006127152A2 (en) * | 2005-04-05 | 2006-11-30 | University Of Southern California | Methods for making and using regulatory t cells |
| WO2007121233A1 (en) | 2006-04-12 | 2007-10-25 | Genzyme Corporation | Methods of treating autoimmune diseases |
| US20100034782A1 (en) * | 2006-05-31 | 2010-02-11 | Nader Najafian | Methods of Using Anti-Thymocyte Globulin and Related Agents |
| WO2010049935A1 (en) * | 2008-10-30 | 2010-05-06 | Yeda Research And Development Co. Ltd. | Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment |
| AU2009314704A1 (en) * | 2008-11-13 | 2010-05-20 | Instituto De Medicina Molecular | Foxp3+ natural kiler T-cells and the treatment of immune related diseases |
| CN102971416B (zh) | 2010-04-22 | 2018-03-30 | 南加州大学 | 用于扩增和稳定天然调节性t细胞的方法和组合物 |
| US20110312886A1 (en) * | 2010-06-16 | 2011-12-22 | Allergan, Inc. | TGF-ß AND METHODS OF TREATING OCULAR AND OTHER DISEASES |
| ES2589678T3 (es) | 2010-09-08 | 2016-11-15 | Yeda Research And Development Co. Ltd. | Uso de linfocitos T de memoria central anti-terceros para el tratamiento anti-leucemia/linfoma |
| SG11201400513PA (en) | 2011-09-08 | 2014-06-27 | Yeda Res & Dev | Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment |
| CN106110326A (zh) | 2011-10-12 | 2016-11-16 | 思佰益药业股份有限公司 | 移植器官的成活促进剂 |
| WO2013131045A1 (en) | 2012-03-02 | 2013-09-06 | The Regents Of The University Of California | Expansion of alloantigen-reactive regulatory t cells |
| WO2014010206A1 (ja) | 2012-07-13 | 2014-01-16 | Ｓｂｉファーマ株式会社 | 免疫寛容誘導剤 |
| WO2014186193A1 (en) * | 2013-05-17 | 2014-11-20 | Abwiz Bio, Inc. | T regulatory cells and uses thereof |
| AU2016291825B2 (en) | 2015-07-16 | 2022-08-11 | Yeda Research And Development Co. Ltd. | Genetically modified anti-third party central memory T cells and use of same in immunotherapy |
| US20180251731A1 (en) * | 2015-09-07 | 2018-09-06 | INSERM (Institute National de la Santé et de la Recherche Médicale) | Subpopulation of cd8+cd45rclow tregs and uses thereof |
| US10751368B2 (en) | 2017-01-18 | 2020-08-25 | Yeda Research And Development Co. Ltd. | Methods of transplantation and disease treatment |
| ES3064681T3 (en) | 2017-01-18 | 2026-04-28 | Yeda Res & Dev | Genetically modified veto cells and use of same in immunotherapy |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6406696B1 (en) | 1989-10-27 | 2002-06-18 | Tolerance Therapeutics, Inc. | Methods of stimulating the immune system with anti-CD3 antibodies |
| NZ249754A (en) | 1992-03-04 | 1997-06-24 | Schering Corp | Interleukin-10 and its use in inhibiting graft vs host disease or tissue rejection |
| US6277635B1 (en) | 1992-03-04 | 2001-08-21 | Schering Corporation | Use of interleukin-10 to produce a population of suppressor cells |
| US20020182730A1 (en) * | 1995-07-26 | 2002-12-05 | Micheal L. Gruenberg | Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| ES2198774T3 (es) * | 1997-11-05 | 2004-02-01 | University Of Southern California | Utilizacion de citoquinas y nitrogenos para inhibir respuestas inmunes patologicas. |
| US20030157057A1 (en) * | 1999-05-05 | 2003-08-21 | Horwitz David A. | Methods for the induction of professional and cytokine-producing regulatory T cells |
| US6358506B1 (en) | 1997-11-05 | 2002-03-19 | University Of Southern California | Use of cytokines and mitogens to inhibit pathological immune responses |
| EP1061949B1 (de) | 1998-03-03 | 2009-07-15 | University of Southern California | Zytokinen und mitogenen um "graft-versus-host disease" zu verhindern |
| US6803036B1 (en) * | 1998-03-03 | 2004-10-12 | University Of Southern California | Use of cytokines, cells and mitogens to inhibit graft versus host disease |
| US6368636B1 (en) * | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| ES2311462T3 (es) | 1999-05-05 | 2009-02-16 | University Of Southern California | Uso de citocinas y mitogenos para inhibir las respuestas inmunes patologicas. |
| ATE431399T1 (de) | 1999-09-01 | 2009-05-15 | Univ Southern California | Verwendung von cytokinen, zellen und mitogene zur hemmung der graft-versus-host krankheit |
| US6685936B2 (en) * | 1999-10-12 | 2004-02-03 | Osiris Therapeutics, Inc. | Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation |
| ATE460475T1 (de) * | 2000-04-11 | 2010-03-15 | Univ Southern California | Methode zur verhinderung der transplantatabstossung unter verwendung von tgf- beta zur induktion von t-suppressorzellen |
-
2001
- 2001-04-11 AT AT01926893T patent/ATE460475T1/de not_active IP Right Cessation
- 2001-04-11 WO PCT/US2001/011898 patent/WO2001077299A2/en not_active Ceased
- 2001-04-11 AU AU5340001A patent/AU5340001A/xx active Pending
- 2001-04-11 AU AU2001253400A patent/AU2001253400B2/en not_active Ceased
- 2001-04-11 US US09/833,526 patent/US6759035B2/en not_active Expired - Lifetime
- 2001-04-11 JP JP2001575153A patent/JP5008810B2/ja not_active Expired - Fee Related
- 2001-04-11 CA CA002405806A patent/CA2405806A1/en not_active Abandoned
- 2001-04-11 EP EP01926893A patent/EP1274833B1/de not_active Expired - Lifetime
- 2001-04-11 DE DE60141510T patent/DE60141510D1/de not_active Expired - Lifetime
-
2004
- 2004-02-04 US US10/772,768 patent/US20040185034A1/en not_active Abandoned
-
2007
- 2007-10-30 US US11/929,254 patent/US20080318313A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20080318313A1 (en) | 2008-12-25 |
| CA2405806A1 (en) | 2001-10-18 |
| JP5008810B2 (ja) | 2012-08-22 |
| US20040185034A1 (en) | 2004-09-23 |
| WO2001077299A3 (en) | 2002-03-28 |
| WO2001077299A2 (en) | 2001-10-18 |
| EP1274833A2 (de) | 2003-01-15 |
| DE60141510D1 (de) | 2010-04-22 |
| AU2001253400B2 (en) | 2007-03-01 |
| US6759035B2 (en) | 2004-07-06 |
| EP1274833B1 (de) | 2010-03-10 |
| US20020006392A1 (en) | 2002-01-17 |
| AU5340001A (en) | 2001-10-23 |
| JP2003530101A (ja) | 2003-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60141510D1 (de) | Methode zur verhinderung der transplantatabstossung unter verwendung von tgf-beta zur induktion von t-suppressorzellen | |
| ATE458506T1 (de) | Knochenmarkersatzmaterial-verbundwerkstoff, verfahren zu seiner herstelllung und kit | |
| ATE430807T1 (de) | Verfahren zur kultivierung von circovirus | |
| ATE382681T1 (de) | Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen | |
| DE60123284D1 (de) | Stabile feste enzymzusammensetzungen und verfahren zur ihrer verwendung | |
| DE60125342D1 (de) | Humane pankreatische epitheliale stammzellen, verfahren zur ihrer isolierung und verwendungen davon | |
| DK0871414T3 (da) | Fremgangsmåder til fremstilling af væv til implantering | |
| ATE424147T1 (de) | Biotechnisch erzeugte gefässprothese für die implantation | |
| WO2003092471A3 (en) | Cell-seeded extracellular matrix grafts | |
| ATE424164T1 (de) | Verfahren zur herstellung einer gefässprothese | |
| EP1082057A4 (de) | Biologisch modellierte implantierbare prothesen | |
| SG152273A1 (en) | Pdx1 expressing endoderm | |
| WO2003039489A3 (en) | Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof | |
| EA200800996A1 (ru) | Способ получения т-клеточной популяции | |
| CO5601047A2 (es) | Metodo de cultivo celular libre de animal | |
| NO20033396D0 (no) | Forbedret in vitro fremgangsmåte for kultivering av mammale celler for autolog celle implantasjon/transplantasjon fremgangsmåter | |
| DE50101920D1 (de) | Verfahren zur herstellung eines bioartifiziellen transplantates | |
| IS2631B (is) | Aðferðir þar sem integrín-mótlyf eru notuð til að meðhöndla margföld mergæxli og uppsog í bein af völdum mergæxla | |
| ATE344321T1 (de) | Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen | |
| NO20063772L (no) | Sammensetninger og fremgangsmater vedrorende dyrking av neural stamceller med benmarg fra stromaceller | |
| WO2000041713A3 (en) | Composition and method for improving function of embryonic kidney transplants | |
| WO2006107850A3 (en) | Preventing rejection of transplanted tissue using regulatory t cells | |
| WO2005017115A3 (en) | Cord blood-derived hematopoietic progenitor cells | |
| WO1999061589A3 (en) | Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof | |
| DE60136558D1 (de) | Verfahren zur kultivierung humaner chondrozyten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |